A.) I don't think CC has a muzzle in place. Are there things he can't divulge right now? Absolutely. Are they things that are the equivalent of the US Government pulling out a flying saucer from Area 51 and doing a tour of the country? I highly doubt it.
B.) I feel the groundhog day pattern we're seeing is a combination of regular MM activity, shorts following the FINRA schedule, and the low volume this stock exhibits. Any 3rd party loading up on the stock would've been done a long time ago (it wouldn't take 8 months to do it).
1.) I don't think toxicity has any direct impact on the stock price. Toxicity is really only a problem if it's killing people in the process of trying to cure them/address a symptom.
2.) Collaboration with Intel is nice, but is only transactional in nature ($ENZC is using Intel's AI product). The white paper helped bring awareness to what both Intel and $ENZC are doing, but isn't a high dollar buyout/partnership/investment round from Intel into $ENZC.
3.) $ENZC placed an order with Samsung Biologics, that's it. There's no buyout/investment round/investment from Samsung directly into $ENZC itself.
4.) $ENZC projected earnings are made up numbers. It's like proforma in real estate: If the market conditions are perfect and the company executes absolutely flawlessly, then maybe they can expect to hit the numbers. I actually believe $ENZC numbers are on the low side, if they're truly doing what they say they're going to do.
Also, patents are worthless until someone actually builds it. I know $ENZC is working to build out some of their patents to show they work, but until then, I think BP, and the broader market, are in a wait and see holding pattern.
I have faith $ENZC will surprise us all, and I believe the current share price is justified based on the current public information available.
IMO
GLTA
Cheers!
News 
Market Data 
Discover 
